Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 5:05 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1777–1800 of 4,073 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Self-study Clear all

Conditions: Cocaine Dependence
Interventions: Doxazosin, Modafinil, cocaine, Placebo; Drug
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 55 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Bladder Cancer, Brain and Central Nervous System Tumors, Breast Cancer, Esophageal Cancer, Extragonadal Germ Cell Tumor, Gastric Cancer, Lung Cancer, Ovarian Cancer, Prostate Cancer
Interventions: lapatinib, paclitaxel; Drug
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Multiple Sclerosis
Interventions: Rebidose®; Device
Lead sponsor: EMD Serono; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 109 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Rockland, Massachusetts

Conditions: Suicide, Surveillance, Mental Health, Substance Use, Depressive Symptoms
Interventions: New Hope (NH), Elders Resilience (ER), Case Management (CM); Behavioral · Other
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 16 Years to 29 Years
Enrollment: 304 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Whiteriver, Arizona

Conditions: Hearing Loss
Interventions: Phonak Audeo Lumity Receiver in Canal Hearing Aid; Device
Lead sponsor: University of South Florida; Other
Eligibility: 55 Years to 75 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Stroke
Interventions: Learning in a Virtual Environment (LIVE); Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Stress Disorders, Post-Traumatic
Interventions: Prolonged Exposure (PE), Treatment as usual group therapy (TUGT), Supportive counseling (SC); Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years to 67 Years · Female only
Enrollment: 187 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2009
U.S. locations: 2
States / cities: Philadelphia, Pennsylvania

Conditions: Marijuana Abuse
Interventions: AEF0117, Placebo oral capsule; Drug
Lead sponsor: Aelis Farma; Industry
Eligibility: 21 Years to 60 Years
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Cervical Cancer
Interventions: Not listed
Lead sponsor: MetroHealth Medical Center; Other
Eligibility: 30 Years to 65 Years · Female only
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Migraine
Interventions: "Investigational"Auto-injector (sumatriptan succinate); Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 73 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 10
States / cities: San Francisco, California • Stamford, Connecticut • Chicago, Illinois + 7 more

Conditions: Opioid Misuse, Trauma Injury
Interventions: Opioid Risk Monitoring (ORM), enhanced Trauma Care Coordination (eTCC), Pain Coping Skills Training - Brief (PCST-LITE), Standard Trauma Care Coordination (sTCC), Pain Coping Skills Training - Plus (PCST+), Pain Coping Skills Training - Maintenance (PCST-M); Other · Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 65 Years
Enrollment: 118 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Madison, Wisconsin • Milwaukee, Wisconsin

Conditions: Diabetes Mellitus, Type 2
Interventions: Patient education, self-monitoring of blood glucose and remote patient monitoring of blood glucose; Behavioral
Lead sponsor: Sutter Health; Other
Eligibility: 30 Years to 70 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Osteo Arthritis Knee, Pain
Interventions: Intervention -- "Headspace" mindfulness application, Control -- "My Water Balance" application; Device
Lead sponsor: jilliansylvester; Federal
Eligibility: 18 Years to 74 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Scott Air Force Base, Illinois

Conditions: REM Sleep Behavior Disorder
Interventions: Adalimumab, Placebo; Drug
Lead sponsor: Yale University; Other
Eligibility: 50 Years to 80 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 17
States / cities: Los Angeles, California • Aurora, Colorado • North Haven, Connecticut + 13 more

Conditions: Cancer, Young Adult, Pain, Psychological Distress, Fatigue, Breast Cancer, Melanoma, Hematologic Cancer, Germ Cell Tumor, Endocrine Cancer
Interventions: Behavioral Symptom Management for Young Adult Cancer Survivors; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 39 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Complication of Transplanted Lung
Interventions: Aztreonam Lysine for Inhalation (AZLI), Status Post Lung Transplant; Drug · Procedure
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Los Angeles, California • Durham, North Carolina

Conditions: Psychotic Disorders
Interventions: Mobile After-Care Support (MACS) app; Behavioral
Lead sponsor: Butler Hospital; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Atrial Fibrillation
Interventions: Placebo, Etripamil; Drug
Lead sponsor: Milestone Pharmaceuticals Inc.; Other
Eligibility: 18 Years and older
Enrollment: 750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 4
States / cities: West Hills, California • Littleton, Colorado • Haddon Heights, New Jersey + 1 more

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8
Interventions: Tai Chi, FitBit, Support Group Therapy, Questionnaire Administration, Quality-of-Life Assessment; Other · Device
Lead sponsor: Thomas Jefferson University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Asthma
Interventions: Group 1, Group 2, Group 3; Behavioral
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004
U.S. locations: 1
States / cities: New York, New York

Conditions: Diabetes Mellitus, Type 2, Medication Adherence, HYPERGLYCEMIA
Interventions: Diabetes medication management; Other
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Drug Use
Interventions: Usual Care, QUIT Intervention (doctor brief advice, video doctor, health coaching sessions at 2- and 6-weeks), QUIT-Mobile (QUIT Intervention plus weekly mobile-web app or text message weekly self-monitoring, automated feedback over 12 months); Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 457 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 5
States / cities: Long Beach, California • Los Angeles, California

Conditions: Perceived Stress, Anxiety, Sleep Disturbance
Interventions: "Calm" is a mindfulness meditation mobile app; Other
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 99 Years · Female only
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: End Stage Renal Disease, Chronic Pain, Opioid Dependence
Interventions: Pain Coping Skills Training (PCST), Buprenorphine; Behavioral · Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years and older
Enrollment: 643 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 16
States / cities: West Haven, Connecticut • Chicago, Illinois • Boston, Massachusetts + 11 more

Search by objective public record fields.

Complementary Combination Therapy for Cocaine Dependence

Lapatinib and Paclitaxel in Treating Patients With Advanced Solid Tumors

The Multicenter, Open-label, Single-use Autoinjector Convenience Study

Southwest Hub for American Indian Youth Suicide Prevention Research

Early Age-Related Hearing Loss Investigation Pilot Study

Self-management EdUcation and SuPport to Promote PsychOsocial Health Among StRoke Survivors and Informal Caregivers in a VirTual Stroke Community (SUPPORT)

Prolonged Exposure Therapy for Post Traumatic Stress Disorder Following Sexual Assault

Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects

Community Outreach-based Study to Increase Cervical Cancer Screening Among Hispanic Women in Cleveland

A Study to Assess an Auto-injector Being Used to Treat a Migraine Attack

Screening in Trauma for Opioid Misuse Prevention - an Adaptive Intervention

Telehealth Remote Patient Monitoring Study in People With Type 2 Diabetes

Use of a Self-Guided Mindfulness Mobile Application to Improve Pain Outcomes in Individuals With Knee Osteoarthritis

An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)

Symptom Management for YA Cancer Survivors

Safety Study of Aztreonam Lysine for Inhalation (AZLI) in the Treatment of Early Bronchiolitis Obliterans Syndrome (BOS)

Mobile After-Care Intervention to Support Post-Hospital Transition (MACS)

ReVeRA-301: Etripamil in Atrial Fibrillation Phase 3

Tai Chi for Relieving Aromatase Inhibitor-Induced Arthralgia in Patients With Stage I-III Breast Cancer, the TaiChi4Joint Trial

Pilot Study of Changing Exercise and Physical Activity Behavior in Asthma Patients

The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 Diabetes

mHealth to Enhance & Sustain Drug Use Reduction of the QUIT BI in Primary Care

Effects of Using Mobile App on Perceived Stress During COVID-19 Pandemic

HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis